China NMPA Product Recall - Alinity m System, a fully automated real-time fluorescence nucleic acid amplification and analysis system

The National Medical Products Administration (NMPA) has announced a Class II voluntary recall affecting Abbott Molecular Inc.'s fully automated real-time fluorescent nucleic acid amplification analysis system, the Alinity m System (National Medical Device Registration Certificate No. 20243220544). This action was reported by Abbott Trading (Shanghai) Co., Ltd. The primary issue prompting this recall is an identified design defect within the solution chamber shell of the product system. This flaw directly impacts the functionality and safety of the Alinity m System, necessitating its removal from use. As a required action, Abbott Molecular Inc. is implementing this voluntary recall to address the product deficiency and safeguard public health. The recall, managed under the NMPA's regulatory framework, demands that specific details regarding affected models, specifications, and batch numbers are provided in an accompanying Medical Device Recall Event Report Form. This event highlights the robust oversight exercised by the NMPA in monitoring medical device quality and ensuring manufacturers adhere to stringent safety and design standards, requiring prompt corrective measures when defects are discovered.